Skip to content

CKD Specific Telemonitoring Platform to Minimize Adverse Outcomes in High Risk CKD Patients

End Stage Renal Disease | Chronic Kidney Disease Stage 5

The main purpose of this trial is to determine whether the addition of the VIEWER virtual care platform to usual care will lead to a reduction in composite emergency department (ED) visits and/or hospitalizations/or increase the perceived safety of virtual care among patients and providers.

null

Conditions de participation

  • Sexe:

    ALL

  • Âges admissibles:

    18 and up

Critères de participation

Inclusion Criteria:

* \>18 years of age
* Patient or primary caregiver can read and speak English
* Patient or patients substitute decision maker is able to provide informed consent
* Patient or primary care giver cognitively and physically capable and willing to use the VIEWER mobile application and perform self-measurements (i.e. weight, BP, etc.)
* Have stage 5 CKD (2 measurements of eGFR \<15ml/min/1.73m2); eGFR will be calculated with the CKD-EPI equation.
* Followed in a multidisciplinary CKD clinic
* Have \>40% chance of beginning dialysis in the next 2 years based on the Kidney Failure Risk Equation

Exclusion Criteria:

* Inability of self or caregiver assisted self-monitoring using VIEWER

Lieu de l'étude

Chronic Disease Innovation Centre, Seven Oaks Hospital
Chronic Disease Innovation Centre, Seven Oaks Hospital
Winnipeg, Manitoba
Canada

Contactez l'équipe d'étude

Primary Contact

Reid Whitlock

London Health Sciences Centre
London Health Sciences Centre
London, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Kathleen Koyle

Scarborough Health Network - General Hospital
Scarborough Health Network - General Hospital
Scarborough, Ontario
Canada

Contactez l'équipe d'étude

Primary Contact

Harika Kuppala

Étude parrainée par
University of Manitoba
Participants recherchés
Plus d'informations
ID de l'étude: NCT05726526